| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |